Skip to content
Dx

ICD-10-CM 2027 diagnosis code

E88.09Other disorders of plasma-protein metabolism, not elsewhere classified

✓ Billable / specific

E88.09 is a valid, billable ICD-10-CM code for other disorders of plasma-protein metabolism, not elsewhere classified. It can be reported on claims for dates of service from October 1, 2026 – September 30, 2027.Short description: Oth disorders of plasma-protein metabolism, NEC

Looking up by condition? See ICD-10 code for Analbuminemia, ICD-10 code for Bisalbuminemia, ICD-10 code for Dysproteinemia, ICD-10 code for Hypoalbuminemia.

Code unchanged since ICD-10-CM took effect on October 1, 2015. Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data

About E88.09

E88.09 is the ICD-10-CM diagnosis code for other disorders of plasma-protein metabolism, not elsewhere classified. It belongs to category E88 (other and unspecified metabolic disorders), block E70-E88 (metabolic disorders) and chapter 4 (endocrine, nutritional and metabolic diseases). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.

Within E88.0, choose E88.09 (Other disorders of plasma-protein metabolism, not elsewhere classified) only when documentation doesn't support a more specific option: Alpha-1-antitrypsin deficiency (E88.01) and Plasminogen deficiency (E88.02).

Use an additional code for: codes for associated conditions.

It is not a CC or MCC, so as a secondary diagnosis it doesn't change the MS-DRG severity level.

In MS-DRG v44.0, it is part of the grouping logic for DRG 826 (Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures with MCC, relative weight 4.7581), DRG 827 (Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures with CC, relative weight 2.3896), DRG 828 (Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures without CC/MCC, relative weight 1.6955), DRG 829 (Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Other Procedures with CC/MCC, relative weight 3.1281), DRG 830 (Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Other Procedures without CC/MCC, relative weight 1.4859), DRG 843 (Other Myeloproliferative Disorders or Poorly Differentiated Neoplastic Diagnoses with MCC, relative weight 1.9453) and 2 more, in MDC 17 (Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.

It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.

Before ICD-10, this condition was coded in ICD-9-CM as 273.8 (other disorders of plasma protein metabolism).

Coding notes

Applicable toConditions and synonyms classified to this code
  • Bisalbuminemia

Notes that apply from higher levels

Instructions written at a parent level also apply to E88.09.

› From E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
Excludes1
  • monoclonal gammopathy (of undetermined significance) (D47.2)
  • polyclonal hypergammaglobulinemia (D89.0)
  • Waldenström macroglobulinemia (C88.00)
Excludes2
  • disorder of lipoprotein metabolism (E78.-)
› From E88 Other and unspecified metabolic disorders
Excludes1
  • histiocytosis X (chronic) (C96.6)
Use additional code
  • codes for associated conditions

Broader instructions also apply from E70-E88 Metabolic disorders and Chapter 4: Endocrine, nutritional and metabolic diseases.

Alphabetic index entries

15 entries

Terms in the official ICD-10-CM index that lead to E88.09.

MS-DRG v44.0 grouping

All DRGs →

Inpatient MS-DRGs this diagnosis can group to, as the principal or a secondary diagnosis, depending on the rest of the claim.

ICD-9-CM equivalent

Converter →
  • 273.8Other disorders of plasma protein metabolismapproximate

From the CMS 2018 General Equivalence Mappings (GEMs), the final GEMs release.

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
  • No changes since FY2016.

Common questions about E88.09

Is E88.09 billable?

Yes. E88.09 is a billable/specific ICD-10-CM code valid for FY2027 (October 1, 2026 – September 30, 2027).

Can E88.09 be used as a principal diagnosis?

Yes. The Medicare Code Editor doesn't restrict E88.09 as a principal diagnosis.

Is E88.09 a CC or MCC?

No. E88.09 is neither a CC nor an MCC under MS-DRG v44.0.

What DRG does E88.09 group to?

E88.09 is used in the MS-DRG v44.0 logic for MS-DRG 826 (Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures with MCC), MS-DRG 827 (Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures with CC), MS-DRG 828 (Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures without CC/MCC), MS-DRG 829 (Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Other Procedures with CC/MCC), MS-DRG 830 (Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Other Procedures without CC/MCC), MS-DRG 843 (Other Myeloproliferative Disorders or Poorly Differentiated Neoplastic Diagnoses with MCC) and 2 more. Which one applies depends on whether it is the principal diagnosis and on the rest of the claim.

What is the ICD-9 code for E88.09?

The CMS General Equivalence Mappings map E88.09 to ICD-9-CM 273.8.